Expansion of the facility portfolio of the internal research centre nanoterapeutics (Q9611)

From EU Knowledge Graph
Revision as of 15:41, 27 December 2020 by DG Regio (talk | contribs) (‎Changed an Item: Change because item Q214255 was merged with Q4859)
Jump to navigation Jump to search
Project Q9611 in Czech Republic
Language Label Description Also known as
English
Expansion of the facility portfolio of the internal research centre nanoterapeutics
Project Q9611 in Czech Republic

    Statements

    0 references
    19,500,000.0 Czech koruna
    0 references
    780,000.0 Euro
    10 January 2020
    0 references
    39,000,000.0 Czech koruna
    0 references
    1,560,000.0 Euro
    10 January 2020
    0 references
    50 percent
    0 references
    4 November 2016
    0 references
    30 May 2018
    0 references
    1 June 2018
    0 references
    Therapharm, a.s.
    0 references
    0 references

    50°10'4.12"N, 14°6'28.30"E
    0 references
    27309
    0 references
    Žadatel se pátým rokem zabývá průmyslovým výzkumem a vývojem v oblasti nanoterapeutik s totální biokompatibilitou. Cílem projektu je rozšířit portfolio dostupných metod a technik, tak aby bylo možné provádět většinu klíčových výzkumných aktivit interně a eliminovat tak vysoké riziko ztráty know-how. (Czech)
    0 references
    For the fifth year, the applicant is engaged in industrial research and development in the field of nanotherapeutics with total biocompatibility. The aim of the project is to expand the portfolio of available methods and techniques so that the majority of key research activities can be carried out internally to eliminate the high risk of loss of know-how. (English)
    22 October 2020
    0 references

    Identifiers

    CZ.01.1.02/0.0/0.0/15_002/0000129
    0 references